| Scorecard |
|---|
|
3 / 5 Stars
|
|
Lipper
5
2
4
1
5
|
|
Zacks Investment Research
5
(Strong Sell)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
C-
(Hold)
|
Fund Fees
Updated 10.31.2012
| Maximum Sales Fees % | |
|---|---|
| Initial | 4.75 |
| Deferred |
Updated 10.31.2012
| Maximum Fees % | |
|---|---|
| Administrative | |
| Management | 1.0 |
| Redemption |
Updated 10.31.2012
| Actual Fees % | |
|---|---|
| 12b-1 | 0.35 |
| Management | 1.0 |
| Net Expense Ratio: Annual Report | 1.85 |
| Net Expense Ratio: Prospectus | 1.84 |
Updated 06.05.2013
| Total Cost Projections | |
|---|---|
| 3-Year | $1,032.00 |
| 5-Year | $1,441.00 |
| 10-Year | $2,579.00 |
Purchase Information
Updated 08.31.2012
| Minimum Investments | |
|---|---|
| Initial | $2,000.00 |
| Additional | $100.00 |
| Initial IRA | |
| Additional IRA | |
| Initial AIP | |
| Additional AIP |
Contact Fund
Financial Investors Trust (Emerald)
Financial Investors Trust (Emerald)
1290 Broadway, Suite 1100, Denver, CO
US 80203
303.623.2577
